Squarepoint Portfolio holdings
Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$305M |
| 2 |
Procter & Gamble
PG
|
+$300M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$274M |
| 4 |
NVIDIA
NVDA
|
+$268M |
| 5 |
Lowe's Companies
LOW
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$536M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$470M |
| 4 |
ExxonMobil
XOM
|
+$370M |
| 5 |
Amazon
AMZN
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.61% |
| 2 | Technology | 13.44% |
| 3 | Consumer Discretionary | 5.63% |
| 4 | Financials | 5.29% |
| 5 | Healthcare | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
CALL
Nutrien
NTR
$33.8B
| $604K | ﹤0.01% |
8,600
-22,300
| -72% | -$1.59M |
2026 Q1
2 quarters
|
|
3202
Allogene Therapeutics
ALLO
$287M
| $603K | ﹤0.01% |
376,940
+135,416
| +56% | +$258K |
2024 Q2
9 quarters
|
|
3203
PUT
Garmin
GRMN
$55.1B
| $602K | ﹤0.01% |
2,100
+800
| +62% | +$222K |
2022 Q3
16 quarters
|
|
3204
RXO
RXO
$4.67B
| $602K | ﹤0.01% |
+29,418
| New | +$670K |
2026 Q3
0 quarters
|
|
3205
PUT
SM Energy
SM
$7.7B
| $601K | ﹤0.01% |
17,800
-121,500
| -87% | -$4.07M |
2025 Q2
5 quarters
|
|
3206
Caledonia Mining Corp
CMCL
$390M
| $601K | ﹤0.01% |
25,520
+15,405
| +152% | +$339K |
2025 Q4
3 quarters
|
|
3207
Dynex Capital
DX
$2.59B
| $600K | ﹤0.01% |
+53,859
| New | +$685K |
2026 Q3
0 quarters
|
|
3208
enGene Therapeutics
ENGN
$153M
| $599K | ﹤0.01% |
299,747
+84,366
| +39% | +$156K |
2026 Q1
2 quarters
|
|
3209
PUT
Duolingo
DUOL
$7.43B
| $598K | ﹤0.01% |
4,200
-11,800
| -74% | -$1.64M |
2024 Q4
7 quarters
|
|
3210
Oil-Dri
ODC
$1.06B
| $596K | ﹤0.01% |
+6,576
| New | +$616K |
2026 Q3
0 quarters
|
|
3211
Plains All American Pipeline
PAA
$17.2B
| $595K | ﹤0.01% |
25,100
| – | – |
2026 Q1
2 quarters
|
|
3212
Eightco Holdings
ORBS
$282M
| $595K | ﹤0.01% |
+508,186
| New | +$405K |
2026 Q3
0 quarters
|
|
3213
Bel Fuse Inc Class A
BELFA
$2.66B
| $594K | ﹤0.01% |
+3,006
| New | +$656K |
2026 Q3
0 quarters
|
|
3214
PUT
Kimberly-Clark
KMB
$65.8B
| $594K | ﹤0.01% |
6,100
-50,300
| -89% | -$5.37M |
2023 Q2
13 quarters
|
|
3215
Levi Strauss
LEVI
$9.22B
| $593K | ﹤0.01% |
+30,095
| New | +$674K |
2026 Q3
0 quarters
|
|
3216
Broadridge
BR
$21.7B
| $591K | ﹤0.01% |
3,670
-135,502
| -97% | -$22.1M |
2021 Q2
21 quarters
|
|
3217
Lineage Inc
LINE
$7.96B
| $591K | ﹤0.01% |
17,321
-24,600
| -59% | -$1000K |
2026 Q2
1 quarter
|
|
3218
PUT
Hormel Foods
HRL
$12B
| $590K | ﹤0.01% |
29,600
-73,400
| -71% | -$1.71M |
2026 Q2
1 quarter
|
|
3219
Organogenesis Holdings
ORGO
$125M
| $590K | ﹤0.01% |
430,583
+177,957
| +70% | +$349K |
2025 Q4
3 quarters
|
|
3220
Red Cat Holdings
RCAT
$602M
| $587K | ﹤0.01% |
+90,916
| New | +$768K |
2026 Q3
0 quarters
|
|
3221
Hippo Holdings
HIPO
$984M
| $587K | ﹤0.01% |
19,083
+10,174
| +114% | +$318K |
2026 Q1
2 quarters
|
|
3222
BitGo Holdings
BTGO
$493M
| $587K | ﹤0.01% |
+79,327
| New | +$486K |
2026 Q3
0 quarters
|
|
|
LTGO
3223
Latigo Biotherapeutics
LTGO
$857M
| $587K | ﹤0.01% |
+35,145
| New | +$742K |
2026 Q3
0 quarters
|
|
3224
Vipshop
VIPS
$6.15B
| $584K | ﹤0.01% |
46,710
-157,634
| -77% | -$2.18M |
2025 Q4
3 quarters
|
|
3225
CALL
Archer Aviation
ACHR
$3.39B
| $584K | ﹤0.01% |
117,500
-5,800
| -5% | -$31.6K |
2025 Q1
6 quarters
|
|
Similar funds
Squarepoint's Q3 2026 Portfolio in Review
As of Q3 2026, Squarepoint held 5,201 positions worth $90.8B, up 0.33% from $90.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Squarepoint withdrew a net $4.18B in Q3 2026, closing 849 positions and reducing 1,820 holdings. Its most notable exit was Electronic Arts, an estimated $146M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Squarepoint opened a new position in AstraZeneca worth $188M.
- Squarepoint's largest Q3 2026 buy was AstraZeneca: 1,161,691 shares worth $188M.
- Squarepoint added most to Costco in Q3 2026, an estimated $305M increase.
- Squarepoint's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.23B.
- Squarepoint fully exited Electronic Arts in Q3 2026, selling an estimated $146M.
- Squarepoint's ten largest holdings make up 22% of its $90.8B portfolio in Q3 2026.
- Squarepoint opened 873 new positions and closed 849 in Q3 2026.
- Squarepoint's portfolio value rose 0.33% quarter-over-quarter to $90.8B.
Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.